Literature DB >> 22527299

[Cutaneous malignant lymphomas. Update on diagnosis and therapy of cutaneous T-cell lymphomas].

D Humme1, M Möbs, S Pullmann, A Haidar, M Beyer, W Sterry, C Assaf.   

Abstract

Cutaneous T-cell lymphomas represent extranodal non-Hodgkin lymphomas of mature T-cells, which accumulate in the skin. They have been recognized as a heterogeneous group with distinct variability in clinical presentation and histopathology, with divergent biological behaviour and prognosis. Therefore the exact diagnosis is an important prerequisite for an adequate and stage-adapted treatment.

Entities:  

Mesh：

Year:  2012        PMID： 22527299     DOI： 10.1007/s00105-012-2387-y

Source DB:  PubMed          Journal:  Hautarzt        ISSN： 0017-8470            Impact factor:   0.751


  48 in total

Review 1.  CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features.

Authors:  H Stein; H D Foss; H Dürkop; T Marafioti; G Delsol; K Pulford; S Pileri; B Falini
Journal:  Blood       Date:  2000-12-01       Impact factor: 22.113

2.  Subcutaneous, blastic natural killer (NK), NK/T-cell, and other cytotoxic lymphomas of the skin: a morphologic, immunophenotypic, and molecular study of 50 patients.

Authors:  Cesare Massone; Andreas Chott; Dieter Metze; Katrin Kerl; Luigi Citarella; Esmeralda Vale; Helmut Kerl; Lorenzo Cerroni
Journal:  Am J Surg Pathol       Date:  2004-06       Impact factor: 6.394

3.  Phase II evaluation of gemcitabine monotherapy for cutaneous T-cell lymphoma.

Authors:  Madeleine Duvic; Rakhshandra Talpur; Sijin Wen; Razelle Kurzrock; Cynthia L David; Narin Apisarnthanarax
Journal:  Clin Lymphoma Myeloma       Date:  2006-07

4.  Combination therapy with extracorporeal photopheresis, interferon-alpha, PUVA and topical corticosteroids in the management of Sézary syndrome.

Authors:  Nina Booken; Christel Weiss; Jochen Utikal; Moritz Felcht; Sergij Goerdt; Claus-Detlev Klemke
Journal:  J Dtsch Dermatol Ges       Date:  2010-02-18       Impact factor: 5.584

Review 5.  EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.

Authors:  Werner Kempf; Katrin Pfaltz; Maarten H Vermeer; Antonio Cozzio; Pablo L Ortiz-Romero; Martine Bagot; Elise Olsen; Youn H Kim; Reinhard Dummer; Nicola Pimpinelli; Sean Whittaker; Emmilia Hodak; Lorenzo Cerroni; Emilio Berti; Steve Horwitz; H Miles Prince; Joan Guitart; Teresa Estrach; José A Sanches; Madeleine Duvic; Annamari Ranki; Brigitte Dreno; Sonja Ostheeren-Michaelis; Robert Knobler; Gary Wood; Rein Willemze
Journal:  Blood       Date:  2011-08-12       Impact factor: 22.113

6.  TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC).

Authors:  Youn H Kim; Rein Willemze; Nicola Pimpinelli; Sean Whittaker; Elise A Olsen; Annamari Ranki; Reinhard Dummer; Richard T Hoppe
Journal:  Blood       Date:  2007-03-05       Impact factor: 22.113

7.  Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma.

Authors:  Elise A Olsen; Youn H Kim; Timothy M Kuzel; Theresa R Pacheco; Francine M Foss; Sareeta Parker; Stanley R Frankel; Cong Chen; Justin L Ricker; Jean Marie Arduino; Madeleine Duvic
Journal:  J Clin Oncol       Date:  2007-06-18       Impact factor: 44.544

8.  Cutaneous lymphomas in Germany: an analysis of the Central Cutaneous Lymphoma Registry of the German Society of Dermatology (DDG).

Authors:  Chalid Assaf; Sylke Gellrich; Matthias Steinhoff; Dorothée Nashan; Franca Weisse; Edgar Dippel; Esther Coors; Anette Stein; Philippa Gollin; Ulrike Henke; Sabrina Adam-Murati; André Koch; Claus-Detlev Klemke; Rudolf Stadler; Wolfram Sterry
Journal:  J Dtsch Dermatol Ges       Date:  2007-08       Impact factor: 5.584

Review 9.  Maintenance therapy in cutaneous T-cell lymphoma: who, when, what?

Authors:  R Dummer; C Assaf; M Bagot; R Gniadecki; A Hauschild; R Knobler; A Ranki; R Stadler; S Whittaker
Journal:  Eur J Cancer       Date:  2007-08-17       Impact factor: 9.162

10.  Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002.

Authors:  Vincent D Criscione; Martin A Weinstock
Journal:  Arch Dermatol       Date:  2007-07
View more
  1 in total

1.  [Anaplastic large-cell lymphoma CD30(+) ALK(+)].

Authors:  L Kollarikova; M Heizerova; M Simaljakova
Journal:  Hautarzt       Date:  2016-04       Impact factor: 0.751
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.